CBCatherine Bowden

Catherine Bowden

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Catherine Bowden has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Conceptualising ‘my data’: Going beyond data security to build trustworthy governance of health data sharing

    by Catherine Bowden, John Ainsworth, James Cunningham, Søren Holm, Caroline A.B. Redhead, Sarah Devaney

    Despite strong support for health research in the UK, many people currently opt not to share their health data because they do not trust that their data will be handled appropriately. This lack of trust is widely acknowledged but what is missing from the literature is a theoretical understanding of what underlies this lack of trust. This article presents an original, empirically-based account of the source of this lack of trust based on interviews conducted with those who were unwilling to share their GP data with NHS Digital’s General Practice Data for Planning and Research (GPDPR) programme. The participants told us that they did not feel the data was being treated as ‘my data’. In this article, we explore what this concept means to our participants and argue that those responsible for sharing health data need to demonstrate commitment to patients’ values and interests as well as data security.


  • Open Access

    Correction: Exploring Consent to Use Real-World Data in Lung Cancer Radiotherapy: Decision of a Citizens’ Jury for an ‘Informed Opt-Out’ Approach

    by Arbaz Kapadi, Hannah Turner-Uaandja, Rebecca Holley, Kate Wicks, Leila Hamrang, Brian Turner, Tjeerd van Staa, Catherine Bowden, Annie Keane, Gareth Price, et al.

  • Open Access

    Exploring Consent to Use Real-World Data in Lung Cancer Radiotherapy: Decision of a Citizens’ Jury for an ‘Informed Opt-Out’ Approach

    by Arbaz Kapadi, Hannah Turner-Uaandja, Rebecca Holley, Kate Wicks, Leila Hamrang, Brian Turner, Tjeerd van Staa, Catherine Bowden, Annie Keane, Gareth Price, et al.

    An emerging approach to complement randomised controlled trial (RCT) data in the development of radiotherapy treatments is to use routinely collected ‘real-world’ data (RWD). RWD is the data collected as standard-of-care about all patients during their usual cancer care pathway. Given the nature of this data, important questions remain about the permissibility and acceptability of using RWD in routine practice. We involved and engaged with patients, carers and the public in a two-day citizens’ jury to understand their views and obtain decisions regarding two key issues: (1) preferred approaches to consent for the use of RWD within the context of patients receiving radiotherapy for lung cancer in RAPID-RT and (2) how RWD use should be best communicated to patients. Individual views were polled using questionnaires at various stages of the jury, whilst group discussion activities prompted further dialogue about the rationale behind choices of consent. Key decisions obtained from the jury include: (1) an opt-out approach to consent for the use of RWD; (2) the opt-out approach to consent should be informed. Furthermore, it was advised that information and communication regarding the consent process and use of RWD should be accessible, clear and available in a variety of formats. It is important that the consent process for patient data use is underpinned by principles of autonomy and transparency with clear channels of communication between those asking for and giving consent. Moreover, the process of seeking consent from patients should be proportionate to the risks presented from their participation.


  • Open Access

    Unlocking the promise of UK health data: considering the case for a charitable GP data trust

    by Caroline A B Redhead, Catherine Bowden, John Ainsworth, Nigel Burns, James Cunningham, Søren Holm, Sarah Devaney

    The UK National Health Service general practice (GP) patient data constitute a rich research resource, but collecting, managing, and sharing patient data present challenges. In May 2021, to address these challenges, substantial changes to the system for processing pseudonymized GP patient data in England were announced. As part of an opt-out process, patient consent to sharing GP data was deemed to have been given. However, when over a million people quickly acted to opt out of the new system, the process was paused, and an engagement exercise commenced, whose aim was to inform a re-designed programme addressing patient concerns. In this article, we present and discuss the findings of the General Practice Data Trust pilot study, which has investigated people’s reasons for opting out of sharing their data, and, looking for practical solutions to their concerns, has discussed with participants the concept of a ‘data trust’ to manage the sharing of patient data. Making a conceptual argument for the use of the (relatively new) charitable incorporated organization as a governance model for a GP data trust, we demonstrate how this could address patients’ concerns and represent a more attractive means of stewarding GP data for research and service planning purposes.


  • Open Access

    Is the Unequal Treatment of Maternal and Paternal Liability Under the Congenital Disabilities (Civil Liability) Act 1976 Justified?

    by Catherine E Bowden

    Under the Congenital Disabilities (Civil Liability) Act 1976 (CDCLA) a child born disabled as a result of an occurrence prior to its birth can bring a claim against the individual responsible for that occurrence. Significantly, mothers are exempt from liability (except in relation to negligent driving) but fathers are not. Since the CDCLA came into force in 1976, there have been significant shifts in the landscape in which it operates: a more gender-neutral model of parenting; transmission of an infection to a sexual partner can be a criminal offence; and growing evidence regarding the impact of prenatal events. In addition, there is a trend for presenting prenatal harm as a problem of individual behaviour. This article presents a timely consideration of the potential for parental liability under the CDCLA and asks whether restricting the exemption of parental liability to mothers but not fathers can be justified. It is argued that the reasons for unequal parental liability in relation to gestational harm are not sufficient to justify restricting the broad exemption to mothers but not fathers and a change in the law is required to bring the CDCLA up to date with advances in the criminal law, society, and medical science.


  • Open Access

    Are We Justified in Introducing Carbon Monoxide Testing to Encourage Smoking Cessation in Pregnant Women?

    by Catherine Bowden

    Smoking is frequently presented as being particularly problematic when the smoker is a pregnant woman because of the potential harm to the future child. This premise is used to justify targeting pregnant women with a unique approach to smoking cessation including policies such as the routine testing of all pregnant women for carbon monoxide at every antenatal appointment. This paper examines the evidence that such policies are justified by the aim of harm prevention and argues that targeting pregnant women in this way is likely to do more harm than good. Routine carbon monoxide testing is particularly problematic as it sends a message to pregnant women that they cannot be trusted either to truthfully answer questions as to whether or not they smoke, or to make decisions in the best interests of themselves and their future children in the way that non-pregnant individuals are. Further, if the aim is to reduce rates of prenatal harm, the evidence suggests that adopting a supportive and empowering approach to prenatal care is the most effective way to achieve this, something that the current policies aimed at pregnant women are in conflict with.


  • Oliver Quick, Regulating Patient Safety: The End of Professional Dominance?

    by Catherine Bowden

    At a time when we are told that we have had enough of experts, a vision of healthcare regulation that signals the potential end of professional dominance might seem fitting. However, far from partaking in the trashing of experts, Oliver Quick offers a vision of regulation which has the potential to protect patients and professionals alike. While it is uncontentious that increased patient safety should be at the heart of healthcare regulation, precisely what this term means and how it should be achieved are far more problematic issues. Well publicised medical disasters, such as those involving Mid Staffordshire NHS Foundation Trust and paediatric heart surgery at Bristol Royal Infirmary, as well political...